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Clostridium difficile is the principal cause of nosocomial
infectious diarrheaworldwide. The pathogenmodifies its flagel-
lin with either a type A or type BO-linked glycosylation system,
which has a contributory role in pathogenesis. We study the
functional role of glycosyltransferases modifying type B fla-
gellin in the 023 and 027 hypervirulent C. difficile lineages by
mutagenesis of five putative glycosyltransferases and biosyn-
thetic genes. We reveal their roles in the biosynthesis of the
flagellin glycan chain and demonstrate that flagellar post-trans-
lational modification affects motility and adhesion-related bac-
terial properties of these strains. We show that the glycosyl-
transferases 1 and 2 (GT1 and GT2) are responsible for the
sequential addition of a GlcNAc and two rhamnoses, respec-
tively, and that GT3 is associated with the incorporation of a
novel sulfonated peptidyl-amido sugar moiety whose structure
is reported in our accompanying paper (Bouche´, L., Panico, M.,
Hitchen, P., Binet, D., Sastre, F., Faulds-Pain, A., Valiente, E.,
Vinogradov, E., Aubry, A., Fulton, K., Twine, S., Logan, S. M.,
Wren, B.W.,Dell, A., andMorris,H.R. (2016) J. Biol. Chem.291,
25439–25449). GT2 is also responsible for methylation of the
rhamnoses.Whereas type Bmodification is not required for fla-
gellar assembly, some mutations that result in truncation or
abolition of the glycan reduce bacterial motility and promote
autoaggregation and biofilm formation. The complete lack of
flagellin modification also significantly reduces adhesion of
C. difficile toCaco-2 intestinal epithelial cells but doesnot affect
activation of humanTLR5.Our study advances our understand-
ing of the genes involved in flagellar glycosylation and their bio-
logical roles in emerging hypervirulent C. difficile strains.
Clostridium difficile, recently reclassified as Peptoclos-
tridium difficile (1), has emerged since the mid-2000s as the
main cause of antibiotic-associated diarrhea within health-
care environments (2). This Gram-positive spore-forming
anaerobe is an opportunistic pathogen that colonizes the
gastro-intestinal tracts of susceptible individuals, leading to
C. difficile infection (3). Those at risk include patients
undergoing antibiotic therapy, the immunocompromised,
and the elderly (4), although increasingly younger people are
affected by C. difficile infection (5).
Genetic typing and sequence analysis have confirmed that
there are at least five distinct lineages ofC. difficile (6, 7), which
can be divided according to the most important PCR ribotypes
(RTs)4: RT017, RT023, RT027, RT078, and a large group
including the 630 strain and the other RTs (8, 9). Our work is
focused on two lineages (RT023 and RT027). The lineage com-
posed primarily of the RT027 strains has spread globally. It has
also been associated with increased severity of disease and is
described as “hypervirulent” (10–12). RT023 is a recently
emerging lineage, prevalent in Europe, and is also often associ-
ated with more severe disease (13). Most strains of C. difficile
produce two cytotoxins, toxin A (TcdA) and toxin B (TcdB),
which cause extensive damage to the epithelial cells of the gas-
tro-intestinal tract and are considered to be essential for C. dif-
ficile disease (14). The production of either TcdA or TcdB has
been found to be essential for C. difficile infection (15, 16).
However, the existence of naturally toxin A-negative strains
suggests that other factors are involved in C. difficile transmis-
sibility, survival, and colonization. C. difficile expresses multi-
ple surface proteins and colonization factors, including cell
surface-associated proteins (surface layer proteins), fibronec-
tin-binding protein A, proteases, heat-shock proteins, and fla-
gella (17–19). Flagella biosynthesis is known to be linked to a
number of other cellular processes, including sporulation,
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adhesion, metabolism, and toxin production (20). The C. diffi-
cile flagella are composed of a single flagellin protein encoded
by a single flagellin gene (fliC), which is called CD0239 in 630
strain and CDR20291_0240 in R20291 strain. C. difficile flagel-
lin is post-translationally modified by an O-linked glycan, and
this post-translational modification (PTM) is essential for
motility (21). Two types of flagellin PTMhave been identified in
C. difficile, which we have previously defined as type A and B,
where typeAhas a simpler structuralmodification of the flagel-
lin than type B (21–23). The flagellin of the first C. difficile
sequenced strain, 630, is modified at up to seven sites with a
type A PTM (21–23), which is composed of an O-linked
N-acetyl glucosamine (GlcNAc) linked to a methylated threo-
nine via a phosphodiester bond (21–23). The genes responsible
for thismodification (CD0240, CD0241, CD0242, CD0243, and
CD0244) are encoded immediately downstream of the flagellin
gene, fliC (21–24). Previous genetic analysis of the hyperviru-
lent RT027 strain revealed that the gene lying downstream of
fliC in the type B modification, glycosyltransferase 1 (GT1
(CDR20291_0241)), was highly similar to CD0240 of 630 (21).
Although the function of the GT1 protein is yet to be con-
firmed, the first sugar of the type B PTM is also an O-linked
N-acetylhexosamine (HexNAc) residue, indicating that the
GT1 proteinmay have a function similar to theCD0240 protein
(22, 25). Beyond this initial sugar, however, the RT027 flagellin
does not contain a phosphodiester-linked amino acid as in type
A flagellin. Instead, it has recently been found to be extended by
two rhamnoses and a novel sulfonated peptidyl amidoglycan
(25).
The differences between type A and type B flagellin struc-
tures are reflected at the genetic level. In this study, bioin-
formatic analyses reveal the presence of two putative gly-
cosyltransferase genes (GT2 (CDR20291_0242) and GT3
(CDR20291_0243)) in type B that are absent in the type A PTM
gene cluster. Additionally, immediately downstream of GT2
and GT3, there are four further predicted coding sequences
(CDR20291_0244-0247) that do not appear to code for glyco-
syltransferases. We also identified putative glycosylation genes
upstream of fliC (CDR20291_0223-0226), which are similar to
rhamnose biosynthesis genes. In addition, we explored which
genes affect flagellin type B modification and investigated the
biological role of flagellin glycosyltransferases from two hyper-
virulentC. difficile lineages, namely RT027 (strain R20291) and
RT023 (strain CD1426). We show that flagellin PTM type B
affects motility and adhesion properties, including adhesion to
intestinal cells, but does not activate human TLR5.
Results
Flagella GlycosylationGenes in RT027 and RT023AreHighly
Similar—We reported the presence of orthologues of the
RT027 flagellin type B modification genes in RT023 strains.
Thus, a BLAST analysis upstream and downstream of the
RT027 flagellin biosynthetic locus identified glycosyltrans-
ferases and glycan biosynthesis genes (Fig. 1A). Downstream of
FIGURE 1. A, a schematic diagram illustrates flagellin type A (present in RT012 and RT017 strains) and type B (present in RT027 and RT023 strains) modification
genes from C. difficile. Flagellar structural genes (fliC and flgB) are colored inwhite, and predicted GTs and remaining putativemodification genes are colored in
gray. The dotted lines indicate that there are homologous genes in PCR ribotypes 012/017 (CD0241–CD0244) andhomologous genes in PCR ribotypes 023/027
(CDR20291_0242–0247). The asterisk indicates predicted GTs that are different in RT027 and RT023 compared with strain 630. CDR20291_0223–0226 are
similar to rmlD, rmlA, rmlC, and rmlB, respectively. The number of coding sequences from CDR20291_R0226 and the fliC gene is also indicated. B, flagella
glycosylation gene RT-PCR. Top, rhamnose biosynthetic genes. Bars below the genes illustrate the amplified regions (1–3) and internal region (Int) amplified as
a control of gene expression by RT-PCR. Bottom, flagella glycosylation locus located downstream of the fliC gene. Bars below the genes illustrate the amplified
regions (4–9). luxS gene amplification was used as a control for constitutive expression, and an internal primer was used to amplify fliC as a control of gene
expression. Control reactions were carried out without reverse transcriptase (No RT) and with a DNA template from genomic DNA (gDNA). RT-PCR was carried
out on RNA extracted during early exponential growth (A) and during late exponential growth (B).
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the RT027 flagellin gene there were three putative glycosyl-
transferase genes (CDR20291_0241, CDR20291_0242, and
CDR20291_0243, which we designate GT1, GT2, GT3, respec-
tively) encoding predicted proteins with similarity to the group
II superfamily of glycosyltransferases, each having a Pfam
domain 00535 (26). In addition, GT2 also appears to have a
methyltransferase domain (Pfam 08241). We identified four
other predicted coding sequences (CDR20291_0244–0247)
downstream of GT3 in the chromosome from strains repre-
senting RT027 and RT023, which may also be involved in this
flagellin PTM(Fig. 1A). TheCDR20291_0244predicted protein
shares some similarity with FemAB superfamily proteins,
which contain an acyltransferase domain (Pfam 02388).
CDR20291_0245 is a putative carbamoyl-phosphate synthetase
with an ATP-grasp domain (Pfam 13535). This family includes
a diverse set of enzymes that possess ATP-dependent carboxy-
late-amine ligase activity. CDR20291_0246 is a putative orni-
thine cyclodeaminase with a conserved domain PRK06046 also
present in alanine dehydrogenase enzymes. CDR20291_0247
shows significant similarity to FdtB (dTDP-6-deoxy-D-xylohex-
3-uloseaminase) from Aneurinibacillus thermoaerophilus and
Xanthamonas campestris. In these organisms, this enzyme has
been shown to be part of the biosynthetic pathway of TDP-D-
Fucp3NAc producing dTDP-D-Fucp3N from dTDP-6-deoxy-
D-xylohex-3-ulose (27, 28). Upstreamof the flagellin biosynthe-
sis genes, in both RT027 and RT023 strains, there were four
genes (CDR20291_0223–0226) that are similar to rhamnose
biosynthetic genes (rmlD, rmlA, rmlC, and rmlB, respectively)
(Fig. 1A).
Additionally, none of the studied genes in Fig. 1A corre-
sponds to a glycosulfotransferase that could potentially be
involved in the biosynthesis of the sulfonated peptidylamido-
sugar moiety.
To determine whether the putative flagellin type Bmodifica-
tion genes upstream and downstream of fliC are co-transcribed
with fliC, RT-PCR was carried out in R20291 (RT027) over the
junctions between CDR20291_0223–0226 and GT1, GT2,
GT3, andCDR20291_0244–0246.We found that the predicted
type B modification genes were co-transcribed in both expo-
nential and stationary growth phase (Fig. 1B).
Mutations in Flagellin Modification Type B Genes Result
in Truncation or Abolition of Flagellin Post-translational
Modification—Disruption of the glycosyltransferase gene
CD0240, as well as CD0241, CD0242, CD0243, CD0244 in 630
strain was previously reported to result in flagellin of different
sizes (23). To further characterize the role of type B modifica-
tion genes in flagellin glycosylation, R20291 mutants in GT1,
GT2,GT3, CDR20291_0245, andCDR20291_0246were gener-
ated by ClosTron mutagenesis. Flagellin samples were studied
by SDS-PAGE andmass spectrometry. On SDS-PAGE, flagellin
of R20291 had a molecular mass around 60 kDa (Fig. 2A). We
also observed a shift in the mass of the flagellin of all flagella
glycosylation mutants, especially in GT1 and GT2, toward
lower molecular weight. Wild type molecular weight was
restored upon complementation in trans of GT1 mutant
(GT1comp) (Fig. 2A).
Gel bands corresponding to flagellin of mutants and corre-
sponding complements were analyzed by nano-LC-MS/MS.
Spectra were manually compared, and the identified glycopep-
tides in the mutants are listed in Table 1. Tandem mass spec-
trometric analyses of flagellin tryptic digests from the GT1
mutant showed peptides to be non-glycosylated. Flagellin iso-
lated from the GT2 mutant harbored glycopeptides with a sin-
gle HexNAc moiety but lacking any further extension of the
glycan. Flagellin isolated from theGT3mutant wasmodified by
a deoxyHex-deoxyHex-HexNAc (with and without methyl
groups) but lacking the terminal sulfonated peptidylamido-
sugar moiety observed in the wild type (25). Similarly, the
CDR20291_0245 and CDR20291_0246 mutants carried the
non-extended core trisaccharide (Table 1). The analysis of
the complemented mutants by mass spectrometry demon-
strated that the flagellar glycan chain is fully restored (data not
shown).
Based on the mass spectrometric data of the mutants and
taking into account the flagellin type B sulfonated peptidyl-
amido-glycan structure reported by Bouche´ et al. (25), we
conclude that the glycosyltransferases GT1 and GT2 are
responsible for the sequential addition of the GlcNAc
and two rhamnoses sugars, respectively, and that GT3,
CDR20291_0245, and CDR20291_0246 are all involved in the
biosynthesis of the terminal sulfonated peptidylamido-sugar
moiety. Given that our bioinformatics analysis suggests that
GT2 could also function as amethyltransferase, we hypothesize
that GT2 is additionally responsible for methylation of the
rhamnoses (Table 1 and Fig. 2B).
Motility, Cell Aggregation, and Biofilm Formation Are
Affected by Flagellin Glycosylation Mutants in RT027 and
RT023 Strains—Flagella type A modification is essential for
motility inC. difficile 630 and RT017 strains (23). To determine
whether flagellin modification type B is also required for motil-
ity, GT1, GT2, GT3, CDR20291_0245, and CDR20291_0246
mutants were assessed. The R20291fliC mutant was used as a
negative control.Measuring bacterialmotility in agar, we found
that GT1 and GT2 knock-out strains were significantly less
motile than wild type R20291 (diameter of 0.8 0.1 cm versus
2.0  0.2 cm) (Fig. 3A). Complementation of these knockouts
restored the motility phenotype (Fig. 3A). Furthermore, GT3,
FIGURE 2. A, Western blotting of flagellin extractions of RT027 wild type and
flagellin modification mutants. Lane M, marker (prestained protein marker;
Fermentas); lane 1, R20291; lane 2, R20291fliC; lane 3, GT1; lane 4, GT2; lane 5,
GT3; lane 6, CDR20291_0245; lane 7, CDR20291_0246; lane 8, GT1comp. B,
schematic diagram illustrates the structure of flagellin type B modification
and the contribution of each GT. Flagellin type B is modified with one
N-acetylglucosamine (white square) linked to two rhamnoses (white circles)
(with or without a methyl group (Me)). White hexagon, terminal peptidyl-
sugar moiety.
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CDR20291_0245, andCDR20291_0246mutants were asmotile
as the parent R20291 strain, suggesting that the first three sug-
ars of the flagella glycan chain are both sufficient and necessary
for full motility of C. difficile.
To study the effect of PTM type B on flagellar assembly, indi-
vidual bacteria were imaged by TEM. The images revealed the
presence of flagella filaments associated with the surface of
R20291 and mutants. The R20291fliC mutant was used as a
negative control (Fig. 3B). In addition, we quantified flagella
filament length of R20291 and its corresponding mutants, and
no significant differences were observed (Table 2). Our results
suggest that type B modification is not required for flagella
assembly.
We next investigated whether flagellin PTM affects cell
aggregation of hypervirulent C. difficile RT027 and observed
increased aggregation in all glycosylation mutants (83 3 m)
versus wild type (R20291) (52 5 m) (Fig. 4A). These results
indicate that flagella post-translational modification type B
affects C. difficile cell aggregation. However, a FliC mutant
strain that completely lacks flagellin aggregates similarly to
R20291, suggesting that flagella per se are not required for cell
aggregation. Complementation of the mutants restored the
original aggregation phenotype (Fig. 4A). Cell surface hydro-
phobicity of wild type and flagellin glycosylation mutants was
measured, and our results show that flagellin PTMmutants are
more hydrophobic than the wild-type and/or R20291fliC (Fig.
4C). Cell viability in PBS1x was affected after 16-h incubation
(Table 3) but in the same way in the wild types (R20291 and
CD1426) and corresponding mutants. Cell aggregation was
visualized by opticalmicroscopy,wheremutants showed a clear
tendency to cell-to-cell aggregate (supplemental Fig. 1).
To determinewhether these observations can be extended to
another strain from a different lineage, we repeated these
experiments using the GT2 mutant in CD1426 (RT023). Anal-
ogous to R20291 (RT027), this mutant (supplemental Fig. 2A)
was less motile compared with the wild type strain (diameter
of 0.8  0.1 cm versus 2.1  0.1 cm) and aggregated more
than the CD1426 mutant (85 1 versus 60 3, respectively)
(supplemental Fig. 2B).
TABLE 1
Glycan structures identified bymass spectrometry present on C. difficile flagellin purified frommutant strains belonging to ribotypes 027 and 023
A checkmark indicates presence, and anX indicates absence. The glycan structures of wild-type of both RT027 and RT023 have been described in the accompanying article
(25) and are shown as a reference.
FIGURE 3. Motility and flagella production in flagellin modification
mutants. A, quantification of the motility halo of RT027 WT (R20291) and
correspondingmutants (fliC, GT1,GT2,GT3, R20291_0245, andR20291_0246)
and complements (GT1comp andGT2comp). Measurements are in cm. Aster-
isks, significant differences comparedwithWTs (p 0.05). Data are presented
as the mean  S.E. (error bars), n  3. B, electron transmission images of
R20291and its corresponding flagellinmodificationmutants.Arrows, flagella;
bar, 0.5 nm.
TABLE 2
Measurement of flagella filament length
Strains Length of flagella filament S.E.a
m
R20291 3.62 0.42
GT1 3.55 0.46
GT2 3.60 0.40
GT3 3.63 0.33
CDR20291_0245 3.66 0.45
CDR20291_0246 3.64 0.42
a The flagella of 100 bacteria were measured in each strain, and TEM images were
analyzed using the line measuring tool of the Image J 1.50i software (National
Institutes of Health).
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Finally, we determined the role of flagellin modification in
RT027 and RT023 on biofilm on abiotic surface (polystyrene
plates). As shown in Fig. 4B, flagellin type B modification facil-
itates adherence of cells to abiotic surfaces when compared
with the wild type. Complementation of the mutants restored
the original phenotype.
C. difficile Flagellin Glycosylation Modulates Bacterial
Adherence to Intestinal Epithelial Cells—Having observed dif-
ferences in the glycosylation mutants in aggregation and bio-
film on an abiotic surface, we investigated whether adhesion to
a physiologically relevant biological surface, such as human
intestinal epithelial cells (IECs), may also be affected. Previous
work has shown that theC. difficile R20291fliCmutant adheres
less well to human IECs than the wild type strain (29), but
whether adhesion is influenced by changes in flagellin glycosyl-
ation is unknown. Therefore, wemeasured adherence of FITC-
labeledR20291C. difficile, aswell as the respective flagellin type
B modification mutants, to cultured Caco-2 cells by flow
cytometry (Fig. 5A). Compared with R20291, only the GT1
mutant showed reduced adherence, and complementation
restored the phenotype (Fig. 5B). All other mutants adhered
similarly to R20291 on the tested cell line. These data suggest
that flagellin glycans facilitate adhesion of C. difficile to IECs
and that the presence of just the first sugar in the glycan chain is
sufficient to restore adhesion to wild type levels.
Similarly, the CD1426 GT2 mutant showed no difference in
adherence compared with theWT strain, confirming that GT2
does not affect bacterial adherence to IECs (data not shown).Of
note, no difference in FITC labeling was observed betweenWT
and glycosylation mutants (data not shown).
C. difficile Flagellar Glycosylation Is Not Involved in TLR5
Recognition—TLR5 is part of the human innate immune system
and specifically binds to bacterial flagellin. TLR5 activation
results in the secretion of the cytokine IL-8. The potential
impact of flagellin glycosylation (e.g. masking) on host TLR5
engagement was investigated. Untransfected and TLR5-trans-
fected human HEK293 cells were co-cultured with wild type
C. difficile RT027 and RT023 strains and their respective fla-
gella modification-deficient mutants. 8 h after infection, IL-8
FIGURE 4. Cell aggregation in PBS (A), biofilm formation (B), and cell hydrophobicity (C). All of the type B modification mutants showed a significant
increase in cell aggregation, biofilm formation, andhydrophobicity comparedwithR20291.Asterisks, significantdifferences comparedwithWT (p0.05). Data
are presented as the mean S.E. (error bars) from three independent experiments with three technical replicates each.
TABLE 3
C. difficile viability in PBS1x
cfu/ml were counted when the experiment was set up (initial cfu/ml) and after 16 h
of incubation (final cfu/ml).
Strains Initial cfu/ml S.E. Final cfu/ml S.E.
R20291 2.3 0.2E09 1.3 0.3E07
GT1 2.1 0.4E09 1.0 0.3E07
GT2 2.5 0.3E09 1.5 0.1E07
GT3 2.4 0.3E09 1.3 0.3E07
CDR20291_0245 2.2 0.1E09 1.4 0.2E07
CDR20291_0246 2.2 0.3E09 1.9 0.5E07
GT1comp 2.6 0.2E09 1.3 0.2E07
GT2comp 2.7 0.2E09 1.5 0.3E07
GT3comp 2.2 0.4E09 1.1 0.3E07
CDR20291_0245 comp 2.3 0.2E09 1.3 0.1E07
CDR20291_0246 comp 2.2 0.4E09 1.5 0.3E07
CD1426 2.1 0.2E09 1.6 0.1E07
CD1426_GT2 2.2 0.3E09 1.2 0.2E07
CD1426_GT2comp 2.4 0.5E09 1.5 0.3E07
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secretion into the medium was quantified by ELISA. Minimal
IL-8was recorded in untransfected cells; in contrast, significant
increase in IL-8 was observed in response to the wild type
R20291 (Fig. 6A). The increase was completely abrogated in
response to the R20291fliCmutant, whereas the flagella glyco-
sylation mutants activated TLR5 to a similar extent as the WT
strain (Fig. 6A). The CD1426 glycosylation mutant also dis-
played similar TLR5 engagement as its WT counterpart (Fig.
6B). These observations suggest that the interaction between
TLR5 andC. difficile flagellin is maintained even in the absence
of glycans and therefore that glycosylation of flagellin in C. dif-
ficile does not influence TLR5 binding or activation.
Discussion
C. difficile is a major global healthcare problem. In recent
years, hypervirulent strains, including RT027 and RT023, have
emerged, causingmore severe infections (29, 30). Although the
toxins are the main virulence factors, other features, such as
flagella (31), S-layer protein (32), and sporulation (33), also con-
tribute to bacteria colonization and transmission of the disease.
C. difficile flagellin (FliC) has a role in motility, colonization,
biofilm formation, and toxin production. Moreover, flagellin is
immunogenic and protective in a murine model of C. difficile
infection (34). However, little is known about the role of protein
PTM in C. difficile disease, which has a type A or type B modi-
fication (23, 25). It has also been reported that type A post-
translational modification of flagellin in C. difficile 630 strain
has a contributory effect in pathogenesis (23). However, the
role of type B post-translational modification of flagellin
remains unclear. In this work, we investigated the function of
putative type B flagellin modification genes and demonstrated
the importance of flagellar modification in motility, cell aggre-
gation, biofilm formation, epithelial cell adhesion, and TLR5
recognition.
To study the function of the flagellin type B modification
genes, we generated mutants and studied the consequences for
FIGURE5.Cell adhesion inRT027 flagellinmodificationmutants.C. difficile flagella glycosylationmoieties contribute tobacterial adherence to human IECs.
1  106 Caco-2 cells were infected with 2.5  107 FITC-labeled WT R20291 and flagellin glycosylation isogenic mutants and co-cultured for 1.5 h under
anaerobic conditions. Bacterial adherence was assessed by flow cytometry (A) and quantified as change in median fluorescence intensity (B). Data are
presented as the mean S.E. (error bars) from three independent experiments with three technical replicates each. **, p 0.01; ns, non-significant.
C. difficile Type B Flagellin Affects Motility and Biofilm
DECEMBER 2, 2016•VOLUME 291•NUMBER 49 JOURNAL OF BIOLOGICAL CHEMISTRY 25455
 at LO
N
D
O
N
 SCH
 O
F H
Y
G
IEN
E &
 TRO
PICA
L M
ED
ICIN
E on D
ecem
ber 2, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
flagellin post-translational modification using nano-LC-MS/
MS. Based on our results and knowledge of type B glycosylation
(25), we demonstrated that the flagellin type B PTM locus con-
tains two sequential glycosyltransferase genes (GT1 and GT2)
lying downstream of the fliC gene. Our data suggest that GT1 is
responsible for GlcNAc addition to the flagellin polypeptide,
whereas GT2 appears to be responsible for the extension of this
O-linked monosaccharide with an additional two rhamnose
moieties. Bioinformatic analysis showed that GT2 has a meth-
yltransferase domain (Pfam 08241). We propose that GT2 is
responsible for both the addition and the monomethylation of
these rhamnose residues. Bifunctional glycosyltransferases
have also been reported in other human pathogens, such as
Listeria monocytogenes (35). Interestingly, we found that meth-
ylation of the second rhamnose only occurred in mutants that
were truncated at the trisaccharide, andnot in theWT, suggest-
ing that methylation of this sugar may prevent further exten-
sion of the glycan. Three mutants were found to carry glycans
that were not extended from the trisaccharide and are therefore
predicted to be involved in the biosynthesis of the unusual sul-
fonated peptidylamido-sugar moiety that is found in the WT
(25). These were the putative glycosyltransferase GT3, the
putative carbamoyl-phosphate synthetase CDR20291_0245,
and the putative ornithine cyclodeaminase CDR20291_R0246.
Although it is clear that these enzymes are involved in the
flagellin post-translational modification, their precise roles
remain to be determined. Despite several attempts, we were
unsuccessful in creatingmutants for the two remaining genes in
the PTM locus, namely CDR20291_0244 andCDR20291_0247.
These genes are located on either side of CDR20291_0245 and
CDR20291_0246, downstream from GT1, GT2, and GT3. Our
failure to produce mutants strongly suggests that both genes
are important for the viability ofC. difficile andmay be involved
in essential metabolic pathways.
In many bacteria, such as C. jejuni, the genes coding for the
biosynthesis of the glycan and the corresponding glycosyltrans-
ferases are located adjacent to the biosynthetic flagellar genes
(36). For type B flagellin, it appears that the rhamnose biosyn-
thetic group of genes (CDR20291_0223–0226), similar to
rmlD, rmlA, rmlC, and rmlB, lie upstream of fliC and are co-
transcribed with both the fliC gene and the downstream GT
loci. Our repeated efforts to create mutants in the rhamnose
genes were unsuccessful, which could suggest that these genes
would be involved in metabolic pathways that are essential for
C. difficile viability.
In some bacterial pathogens, flagellin PTM is essential for
bacterial flagellar assembly (37), although in Pseudomonas spp.
andBurkholderia spp., glycosylation is not required for flagellar
assembly (38). Type B flagellin PTM in C. difficile is not
required for flagellar assembly because flagellar GT mutants
still produce flagella. This is similar to type A flagellar modifi-
cation, where glycosylation was also not required for flagellar
filament assembly (21, 23). Several bacterial pathogens, such as
Pseudomonas aeruginosa, decorate their flagellin with sugars
that are not required for motility (39). However, in most of the
bacterial pathogens, flagellar glycosylation does affect motility
(23, 40). The latter was previously shown to be the case for
C. difficile 630, which produces a type A modification (21, 23).
Our current study demonstrates that the flagellin PTM type B
similarly facilitates themotility ofC. difficile RT027 and RT023
strains, possibly by altering the physical properties of the cell.
Flagellin glycosylation can also alter adhesion properties of
the bacterial cells (23). Our results suggest that flagellin PTM
type B has an impact on biofilm formation on abiotic surfaces.
Additionally, flagellin type B glycosylation affects adhesion to
Caco-2 cells, which is a cell model widely used for studying
C. difficile cell adhesion, but it has also its limitations due to an
absence of mucus layer. Further studies on a mucus-producing
cell line could give us a better understanding of the interaction
between C. difficile flagellin glycan and the intestinal tissue.
Cell autoaggregation is a phenomenon observed as the
clumping of cells. The importance of aggregation in virulence
has been strongly implicated for other pathogenic bacteria,
including Yersinia enterocolitica, Vibrio cholerae, and Campy-
lobacter jejuni. In those cases, a defect in cell aggregation
showed a defective colonization phenotype in the correspond-
ing animal model (41–43). However, in C. difficile 630 strain,
an increase in cell aggregation attenuates mouse colonization
(23). Our results indicate that flagellin modification type B
affects C. difficile cell aggregation and biofilm formation. We
FIGURE 6. TLR5 activation in RT027 and corresponding mutants. Glycosylation moieties on C. difficile flagellin do not contribute to TLR5 activation.
Untransfected (HEK-WT) and TLR5-transfected (HEK-TLR5) HEK cells were co-cultured withWT R20291 (A) or CD1426 (B) and their respective flagellin mutants
at a multiplicity of infection of 10. IL-8 protein was quantified 8 h post-infection. Data are presented as the mean S.E. from three independent experiments
with three technical replicates each. *, p 0.05; **, p 0.01; ***, p 0.001.
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also showed that differences in flagellin modification also alter
bacterial cell hydrophobicity, causing increased aggregation of
the cells, which could prevent them from swimming efficiently.
This phenotype might affect the fitness of the bacteria in the
host and also interfere with the immune system. Although the
flagellum is important for bacterial motility, cell aggregation,
and colonization, little is known about the functional role of
flagellar glycosylation in host-bacteria interactions. Activation
of TLR5 by flagellin initiates a powerful host response that pro-
vides essential signals for maintaining intestinal immune
homeostasis (44). In C. difficile, it has been described that the
flagellin protein activates TLR5 in epithelial cells (45), but little
is known about the interaction between flagellin glycosylation
and the immune response in C. difficile. In P. aeruginosa and
Burkholderia cenocepacia flagellin, post-translational modifi-
cationmodulates innate immune responses in human epithelial
cells (46). In the current study, we confirmed that C. difficile
flagellin is required for activation of TLR5, but glycosylation
deficiency did not affect TLR5 signaling. Our data do not, how-
ever, preclude the possibility that the C. difficile flagellin sulfo-
nated peptidylamido-glycans alter the host immune response
in other ways. For example, it has recently been reported that
pseudaminic acid onC. jejuni flagellin interacts with the host in
a TLR5-independent manner by engaging with a sialic acid
binding lectin, consequently promoting anti-inflammatory
immunity (47).
Our study provides clear evidence that the emerging hyper-
virulent C. difficile RT027 and RT023 strains possess at least
two sequential glycosyltransferases (GT1 and GT2), which add
GlcNAc, methyl-rhamnoses, and/or rhamnoses to flagellin,
and highlights the importance of flagellin type B modification
in motility, cell adhesion, and TLR5 engagement.
Experimental Procedures
Bacterial Growth and Culture—C. difficile was routinely
grown on Brazier’s CCEY agar (BioConnection, Leeds, UK)
containing 4% (w/v) egg yolk, 250 mg/ml cycloserine, 8 mg/ml
cefoxitin (Bioconnections), and 1% defibrinated horse blood
(TCS Biosciences, Buckingham, UK), in blood agar (Oxoid,
Hampshire, UK) and in BHI (brain heart infusion medium
(Oxoid)) and BHIS (BHI supplemented with 0.5% (w/v) yeast
(Sigma, Gillingham, UK), 0.1% L-cysteine (Sigma)) broth or
agar. All cultures were grown from glycerol stocks in an anaer-
obic atmosphere (10%CO2, 10%H2, 80%N2) in a DonWhitney
MG500 anaerobic workstation (DonWhitney Scientific Ltd.) at
37 °C. All Escherichia coli strains were grown using Luria-Ber-
tani broth or agar supplemented with 12.5 mg/ml chloram-
phenicol (Sigma) at 37 °C. Plasmid DNA was transferred into
C. difficile R20291 and CD1426 by conjugation from CA434
E. coli, as described previously (48, 49). Strains and plasmids,
used in this study, are shown in Table 4.
TABLE 4
Strains and plasmids used in this study
Strains and plasmids Characteristics Source
Strains
C. difficile
R20291 Hypervirulent PCR ribotype 027, isolated from an outbreak in 2004–2005 Ref. 24
R20291fliC::CT fliCmutant derived from R20291 by ClosTron insertion This study
GT1::CT GT1 mutant derived from R20291 by ClosTron insertion This study
GT2::CT GT2 mutant derived from R20291 by ClosTron insertion This study
GT3::CT GT3 mutant derived from R20291 by ClosTron insertion This study
CDR20291_0245::CT CDR20291_0245 mutant derived from R20291 by ClosTron insertion This study
CDR20291_0246::CT CDR20291_0246 mutant derived from R20291 by ClosTron insertion This study
R20291fliC:: CT::fliC R20291fliCmutant derived from R20291 containing the pMTL-fliC plasmid This study
GT1::CT::GT1 (GT1comp) GT1 mutant derived from R20291 containing the pMTL-GT1 plasmid This study
GT2::CT::GT2 (GT2comp) GT2 mutant derived from R20291 containing the pMTL-GT2 plasmid This study
GT3::CT::GT3 (GT3comp) GT3 mutant derived from R20291 containing the pMTL-GT3 plasmid This study
CDR20291_0245::CT::R0245
(CDR20291_0245comp)
ORF5 mutant derived from R20291 containing the pMTL-CDR20291_0245 plasmid This study
CDR20291_0246::CT::R0246
(CDR202911_0246comp)
ORF6 mutant derived from R20291 containing the pMTL-CDR20291_0246 plasmid This study
CD1426 Hypervirulent PCR ribotype 023, isolated from an outbreak in 2010 Queens Hospital Remford
CD1426_GT2::CT GT2 mutant derived from CD1426 by ClosTron insertion This study
CD1426_GT2::CT::GT2
(CD1426_GT2comp)
GT2 mutant derived from CD1426 containing the pMTL-GT2 plasmid This study
E. coli
Top10 FmcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 nupG recA1 araD139
(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 
Invitrogen
CA434 E. coli HB101 	FmcrB mrr hsdS20(rBmB) recA13 leuB6 ara-14 proA2 lacY1
galK2 xyl-5 mtl-1 rpsL20(Smr) glnV44 
 containing plasmid R702
Ref. 50
Plasmids
pMLT007C-E2-R20291fliC ClosTron plasmid retargeted to fliC at 344/345a DNA 2.0
pMLT007C-E2-GT1 ClosTron plasmid retargeted to GT1 at 478/479s DNA 2.0
pMLT007C-E2-GT2 ClosTron plasmid retargeted to GT2 at 1293/1294s DNA 2.0
pMLT007C-E2-GT3 ClosTron plasmid retargeted to GT3 at 1800/1801s DNA 2.0
pMTL007C-E2-CDR20291_0245 ClosTron plasmid retargeted to CDR20291_0245 at 147/148s DNA 2.0
pMTL007C-E2-CDR20291_0246 ClosTron plasmid retargeted to CDR20291_0246 at 392/393a DNA 2.0
pMTL84153 E. coli–C. difficile shuttle plasmid (pCD6;catP; ColE1tra; fdx promoter) Ref. 51
pMTL-fliC pMTL84151 with fliC cloned with its native promoter This study
pMTL-GT1 pMTL84153 with GT1 cloned behind the fdx promoter This study
pMTL-GT2 pMTL84153 with GT2 and GT3 cloned behind the fdx promoter This study
pMTL-GT3 pMTL84153 with GT3 cloned behind the fdx promoter This study
pMTL-CDR20291_0245 pMTL84153 with CDR20291_0245 cloned behind the fdx promoter This study
pMTL-CDR20291_0246 pMTL84153 with CDR20291_0246 cloned behind the fdx promoter This study
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Growth curves were performed using BHIS medium, and
samples were incubated at 37 °C in an anaerobic atmosphere.
Samples were taken at different time points during the first
24 h. Experiments were performed in three separate biological
replicates, measured as three technical replicates each.
Mutagenesis and Complementation Method—Knockouts of
post-translational flagellin type B genes were constructed by
insertional inactivation of the target genes with the ClosTron
system as described previously (49). Primers are shown in sup-
plemental Table 1. The retargeted plasmids were designed
using the Perutka algorithm at the ClosTron website and syn-
thesized byDNA2.0. Theywere transferred from E. coliCA434
to wild-type R20291 and CD1426 by conjugation, and
transconjugants were selected for on BHIS agar containing 15
g/ml thiamphenicol (Sigma). Chromosomal insertion of the
intron was selected for on BHIS agar containing 20–40 g/ml
lincomycin (Sigma) in R20291 and with 5 g/ml erythromycin
(Sigma) inCD1426.Mutantswere checked by PCR and genome
sequencing.
For complementation studies, genes were amplified by PCR
using primer pairs (supplemental Table 1) and cloned into plas-
mid pMTL84153 to generate the plasmids listed in Table 4.
Each of the constructs was transferred from E. coli CA434 into
C. difficile mutants by conjugation, and transformants were
selected on BHIS plates containing 15 g/ml thiamphenicol
to select for C. difficile containing the retargeted plasmid
integrants.
RNA Isolation and RT-PCR—Bacteria were grown in 10ml of
BHIS overnight at 37 °C. The cell pellet was lysed using the
FASTRNA Pro Blue kit (MP Biomedicals) according to the
manufacturer’s instructions for lysis of Gram-positives. Total
RNAwas extracted using theQiagenRNeasy kit, as described in
the manufacturer’s instructions. The integrity and concentra-
tion of extracted RNA were determined using a Nanodrop
spectrophotometer. RT-PCRs were carried out with random
primers and Superscript II reverse transcriptase (Invitrogen)
according to themanufacturer’s instructions, using 1g of total
RNA. The cDNA was used as amplicon to perform further
PCRs. The PCR program was the following: 94 °C for 2 min; 35
cycles of denaturation (94 °C for 30 s); annealing (50–60 °C for
30 s); 72 °C for 3min; and one extension cycle (72 °C for 5min).
The negative control without reverse transcriptase was carried
out in 5l of diethylpyrocarbonate-treatedwater. Primers used
are listed in supplemental Table 1. luxS gene amplification was
used as a control for constitutive expression, and an internal
primer was used to amplify fliC as a control of gene expression.
We performed experiments in three separate biological repli-
cates, measured as two technical replicates each.
Flagellin Extraction and Western Blotting—Liquid cultures
were grown on BHIS broth overnight, at 37 °C. C. difficile
strains were harvested, washed in phosphate-buffered saline,
and resuspended in a 1:100 volume of low pH glycine (0.2 M
glycine-HCl, pH 2.2) and incubated at room temperature for 30
min with gentle shaking. The cell pellets were removed by cen-
trifugation at 4 °C, and the supernatant was neutralized with
the addition of 2 M Tris to a neutral pH. Flagellin samples were
normalized according to the A600 of the cultures, and a total
volume of 10 l was run on a Nu-Page 4–12% BisTris SDS-
polyacrylamide gel in MOPS running buffer (both from Life
Technologies, Inc.) for 1.5 h. Proteins were transferred to a
nitrocellulose membrane using the iBLOT system (Life Tech-
nologies). Themembrane was blocked in PBS plus 2%milk and
probed with an anti-FliC antibody (a generous gift from the
Armstrong laboratory, University of Calgary, Alberta, Canada)
in PBS plus 0.1% skimmedmilk and 0.1%Tween 20 at a 1:10,000
dilution for 1 h at room temperature. Following standardwash-
ing with PBS plus 0.1% Tween 20, a donkey anti-chicken IR dye
680RD secondary antibody (LI-COR) was added at 1:5000 in
PBS plus 0.1% skimmed milk, 0.01% Tween 20, and 0.01% SDS
and incubated in the dark for 1 h. Themembranewaswashed as
before and visualized using a LI-COR Odyssey system.
Nano-LC-MS/MS Analysis—In preparation for mass spec-
trometry, flagellin samples were digested with trypsin (EC
3.4.21.4; Promega) overnight. Tryptic digests were analyzed by
nano-LC-MS/MS using a reverse-phase nano-HPLC system
(Dionex, Sunnyvale, CA) connected to a quadrupole TOFmass
spectrometer (Q-STAR Pulsar I, MDS Sciex). The digests were
separated by a binary nano-HPLC gradient generated by an
Ultimate pump fittedwith a Famos autosampler and a Switchos
microcolumn switching module (LC Packings, Amsterdam,
The Netherlands). An analytical C18 nanocapillary (75-meter
inside diameter 15 cm; PepMap) and amicro-precolumnC18
cartridge were employed for on-line peptide separation. The
digest was first loaded onto the precolumn and elutedwith 0.1%
formic acid (Sigma) in water (HPLC grade; Purite) for 4 min.
The eluant was then transferred onto an analytical C18 nano-
capillary HPLC column and eluted at a flow rate of 150 nl/min
using the following gradient of solvent A (0.05% (v/v) formic
acid in a 95:5 (v/v) water/acetonitrile mixture) and solvent B
(0.04% formic acid in a 95:5 (v/v) acetonitrile/water mixture):
99% A from 0 to 5min, 99 to 90%A from 5 to 10min, 90 to 60%
A from 10 to 70min, 60 to 50%A from 70 to 71min, 50 to 5%A
from 71 to 75 min, 5% A from 75 to 85 min, 5 to 95% A from 85
to 86 min, and 95% A from 86 to 90 min. Data acquisition
was performed using Analyst QS software with an automatic
information-dependent acquisition function.
Motility and EM—Bacteria were grown on BHIS plates for
24 h at 37 °C.One colonywas inoculated in BHISwith 0.3% agar
(BD Bacto-agar) and incubated in the anaerobic hood at 37 °C
for 48 h. Photographs were captured after the incubation time
with a Canon 600D SLR camera. The diameter of the halo was
also measured. We performed experiments in three separate
biological replicates, measured as three technical replicates
each.
For C. difficile visualization by EM, strains were grown in
BHIS tubes at 37 °C overnight under anaerobic conditions.
Each strain was grown in a total volume of 1 ml and was incu-
bated for 24 h. 500 l of 2.5% paraformaldehyde, 2.5% glutaral-
dehyde, 0.1 M sodium cacodylate, pH 7.4, was added to 500l of
the bacterial culture. Five microliters of each sample were
added to 200 l of deionized water (Sigma). Five microliters
were placed onto a platform-coated 300mesh copper grid for 1
min. The sample was then stained with 10 l of 0.3% phospho-
tungstic acid, pH 7, for 1 min. The phosphotungstic acid was
drained, and the gridwas air-dried before examining on the Jeol
1200EX transmission electronmicroscope. Digital images were
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recorded using a side-mounted AMT 2K CCD Digital camera
supplied by Deben UK Ltd., IP30 9QS.
Cell Aggregation andHydrophobicity Assays—The cell aggre-
gation assay was performed according to Faulds-Pain et al. (23).
Briefly,C. difficile strains were grown on BHIS agar for 24 h and
suspended in PBS to obtain anA600 nm of 10.0 0.1 in a volume
of 5 ml. Following incubation for 16 h at 37 °C in the anaerobic
cabinet, the top 1 ml was removed, and the A600 nm was mea-
sured. The A600 nm of the whole solution was also measured.
Cell aggregation was calculated as the difference between the
A600 nm of the whole solution and the A600 nm of the top 1 ml as
a percentage of the whole solution OD. Bacterial cell suspen-
sions in 1 PBS were fixed with cold methanol 100% and
stained with 1% crystal violet for 1 min. After washing with
distilled water, bacterial cells were mounted on glass slides
using PBS/glycerol (1:1). Imaging was performed with a Leica
microscope (Leith DMRB), Qimaging Retina 2000R FAST1394
camera, and Volocity software (PerkinElmer Life Sciences).
The mutants and their corresponding complements were
compared with the wild type. Cell viability of bacterial suspen-
sions in PBS1X was checked by counting the cfu/ml at the
beginning of the aggregation experiment and after a 16-h incu-
bation.We performed experiments in three separate biological
replicates, measured as three technical replicates each.
Hydrophobicity was determined by a salting out method as
described by Misawa and Blaser (52). Sodium phosphate at 2
mM was used to make serial 2-fold dilutions of 4 M ammonium
sulfate (25 l each) to a final concentration of 0.00195 M in a
U-bottomed 96-well plate. C. difficile strains were grown in
BHIS agar, and a bacterial suspension in 2 mM sodium phos-
phate was used, and the A600 nm was adjusted to 1.0. Twenty-
fivemicroliters of the bacterial suspensionswere dispensed into
each well, and the plate was incubated for 24 h statically in
anaerobic conditions. The minimum concentration of ammo-
nium sulfate allowing cells to aggregate defined the point of
hydrophobicity. We performed experiments in three separate
biological replicates, measured as three technical replicates
each.
Biofilm on Abiotic Surface—This assay was performed as
described (23, 53). BrieflyC. difficile strains were grown in 5ml
overnight. Then 2 ml of BHIS were inoculated in low evapora-
tion 24-well plates at a 1:100 dilution. The cultures were grown
for 6 days, after which the supernatant was carefully removed,
and thewellswerewashedwith PBS. 1% crystal violetwas added
to thewells and incubated at room temperature for 20min. The
wells were then washed with PBS, and the remaining crystal
violet was detached from the cells attached to the surface of the
wells with methanol for 15 min at room temperature. The
A595 nm was measured in a spectrophotometer (BioTek, Swin-
don, UK).We performed experiments in three separate biolog-
ical replicates, measured as three technical replicates each.
Adherence of C. difficile to Caco-2 IECs—Caco-2 cells grown
in DMEM supplemented with 10% FCS and 1% penicillin-
streptomycin (Gibco, Paisley, UK) were seeded at a density of
5  105/well in a 24-well plate and grown for 9 days to obtain
differentiated confluent monolayers (54). Cells were then co-
cultured with 2.5 107 cfu/ml FITC-labeledWT R20291, WT
CD1426, or their respective flagellin glycosylation isogenic
mutants for 1.5 h under anaerobic conditions. Bacterial adher-
encewas assessed by flow cytometry and expressed as change in
median fluorescent intensity of FITC. C. difficile flagellin-hu-
man TLR5 interaction HEK293 cells were kindly provided by
Dr. D. Guilliano (University College London). Untransfected
HEK293 cells were grown in DMEM supplemented with 10%
FCS, 1% penicillin-streptomycin (Gibco), and 100 g/ml
Normocin (InvivoGen, Toulouse, France). TLR5-transfected
HEK293 cells were grown in the same medium with the addi-
tion of 10 g/ml Blasticidin (InvivoGen). Cells were seeded
overnight at a density of 5 105 cells/well in a 24-well plate and
then co-cultured with WT and mutants at a multiplicity of
infection of 10 for 8 h. Supernatants were collected, and IL-8
was measured by ELISA (Peprotech, London, UK) according to
themanufacturer’s instructions.We performed experiments in
three separate biological replicates,measured as three technical
replicates each.
Statistical Analysis—Data were analyzed by Tukey’s multi-
ple-comparison test using Prism software 9 version 4.0
(GraphPad Software, Inc., San Diego, CA). p  0.05 was con-
sidered statistically significant.
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Supplementary table 1. List of oligonucleotides used in this study 
Primers used for screening mutants and make complements             Nucleotide sequence (5’—3’) 
fliCF GGGAAGAAACGTAAATGCACA 
fliCR TTGTGCCCCTAATTTTGCTC 
GT1F TCCTATGCTAAAGGTGAATGGT
T 
GT1R TCCCTAAATCTACTTGTGCTTG
T 
GT2F ACACCAATAGTGGTTAATGA 
GT2R TATGTTTTCACCAGTAGCCA 
GT3F ACCTGTGTAAATGATGAAAG 
GT3R GCATCTTGATGTAAGTATACCT 
CDR20291_0245F TGCGAAAAAGATTTGTGATGA 
CDR20291_0245R CCATCTTGTGAGGCTTCCTT 
CDR20291_0246F CAGTAGAAATAACTACATC 
CDR20291_0246R CAGTAGAAATAACTACATC 
GT2-EBS1δ CAGATTGTACAAATGTGGTGAT
AACAGATAAGTCGATCCAACT
AACTTACCTTTCTTTGT 
GT2-EBS2 TGAACGCAAGTTTCTAATTTCG
GTTGAAGATCGATAGAGGAAA
GTGTCT 
GT2-IBS AAAAGCTTATAATTATCCTTAT
CTTCCGATGGAGGTGCGCCCAG
ATAGGGTG 
GT3-EBS1δ CAGATTGTACAAATGTGGTGAT
AACAGATAAGTCGAGGAATGT
AACTTACCTTTCTTTGT 
GT3-EBS2 TGAACGCAAGTTTCTAATTTCG
GTTTAAAGTCGATAGAGGAAA
GTGTCT 
GT3-IBS AAAAAGCTTATAATTATCCTTA
CTTTACGAGGAAGTGCGCCCAG
ATAGGGTG 
EBS universal CGAAATTAGAAACTTGCGTTCA
GTAAAC 
RAM-F ACGCGTTATATTGATAAAAATA
ATAATAGTGGG 
RAM-R ACGCGTGCGACTCATAGAATTA
TTTCCTCCCG 
GT1EcoRI_F ATAGAATTCATTGGATATAGAA
GAAAGGG 
GT1XbaI_R ATATCTAGATCTATTTGATTAT
ATGTC 
GT2NdeI_F TATGAATACACCAATAGTGGT * 
GT2 EcoRI_R ATCGAATTCACAAGACATTCCT
CATAAAGT  
GT3_EcoRI_F ATAGAATTCAATGAATCACCAA
TAGTG 
 
GT3_XbaI_R ATATCTAGAGTCCTCAGTGAAT 
 S3 
 
TTTCC 
 
CDR20291_0245EcoRI_F ATAGAATTCATGAAAAGATTA
ATGATTTTAGG 
CDR20291_0245XbaI_R ATATCTAGATTAAAAATTTTCT
ATCAT 
CDR20291_0246EcoRI_F ATAGAATTCTATGATAGATATG
AAGCTA 
CDR20291_0246XbaI_R ATATCTAGATTGCTTTATTTGA
TTCTA 
Primers used for RT-PCR 
1F GTCTCAAAGACCACTATATTCT
G 
1R GGTAATATATCATTGGTTTATG
G 
2F CCAAGCCACTGATAAAAACTG 
2R CAAGACCCTGCTCTAT 
3F GGTTTATATGGAATGACAAGC 
3R ACCTTTCTTCTTCAAATAGCT 
4F GACAGTATTAGAGATGGATAG
AG 
4R CAATAGAATCGGCTCCT 
5F GTGAATTAGAAGAATTTGATAC
TG  
5R GCAATAGAATCGGCTCCTCT  
6F GATGAAATCGAAGACTATCAG
C  
6R CATAAGTTTCACATGCAGG  
7F GGCAAATACTTAGACGAGG  
7R GAGTATCAATTCTATTATCAC  
8F GATGAGAGACAGGATTGTGG  
8R CTCCCTGGCAATCTTGTAACC  
9F GATAGAATTAAAAGAACC  
9R GCCTTACTTCATTTCCAC 
luxS-F GTACTTGATGGAGTAAAGG 
luxS-R TTGCATATTCCTTTGCC 
Int-F GTGTCTTGTATTGGGGG 
Int-R CCAGTATCAAGCCAAGCC 
fliCF GGGAAGAAACGTAAATGCACA 
fliCR TTGTGCCCCTAATTTTGCTC 
*5’end is phosphorilated 
 S4 
 
SUPPLEMENTARY FIGURE 1. Optical microscopy images of R20291 and its corresponding flagellin 
modification mutants showing cell aggregation in the mutants. The bar corresponds to 1 µm. 
 
SUPPLEMENTARY FIGURE 2. Motility and cell aggregation assays in RT 023 and GT2 mutant. 
A. Motility in CD1426 (RT023) and corresponding modification mutant and complement; B. Cell 
aggregation in CD1426 and corresponding modification mutant and complement. Data presented as the 
mean ± SEM from 3 independent experiments with three technical replicates each. Significant differences 
are marked with asterisk; p< 0.05. 
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